the placement of atrial pacing leads in patients after cardiac surgery dept. of cardiology, first...
TRANSCRIPT
The Placement of Atrial Pacing Leads in Patients after Cardiac Surgery
Dept. of Cardiology, First Affiliated Hospital, Nanjing Medical University
Jiangang Zou, M.D.; Ph.D.
Introduction
• The incidence of AVB and SND following
open-heart surgery for congenital heart
disease: 1%~4%
• The incidence of bradyarrhythmias after
cardiac transplantation varies from 8% to 23%
• The experience of the permanent pacing after
open-heart surgery is rare
• The placement of atrial pacing leads
Circulation 2008,117:e350-e408
Recommendations for permanent pacing in children, adolescents, and patients with congenital heart disease
Recommendations for permanent pacing in children, adolescents, and patients with congenital heart disease
Recommendation for pacing after cardiac transplantation
The implantation of pacing leads
• Transvenous:
Cephelic/subclavian puncture/active lead
• Epicardial:
small body size
Fontan-type procedures
tricuspid valve replacement
• The placement of atrial pacing leads
Europace 2007,9:426-31
EPI: 18% OF ATRIAL LEADS, 24% OF VENTRICULAR LEADS
ENDO: 5% OF VENTRICULAR LEADS
Lead failures:
Single-lead, VVIR ENDO pacing had higher efficiency and safety than EPI.
Ann Thorac Surg. 2008;85(5):1704-11
• 239 bipolar steroid-eluting epicardial leads in 114 cases
• 12-year follow-up
• Average atrial and ventricular threshold:1.2V/0.5ms
Thresholds of LA and RA: 0.82V/0.5ms and 0.74V/0.5ms
Thresholds of LV and RV: 0.96V/0.5ms and 0.94V/0.5ms
P sensing of LA and RA: 3.4mV and 2.9mV
V sensing of LV and RV: 11.2mV and 7.7mV
• Lead failure: 19(8%)
• Lead survival at 2 and 5 year :
99% and 94% for atrial leads
96% and 85% for ventricular leads
Bipolar steroid-eluting epicardial leads demonstrate excellent sensing characteristics and persistent low pacing threshold
Eur J Cardiothorac Surg 2000;17:455-461
• Transvenous pacing in the pediatric
population is associated with a lower
threshold and lower rate of lead-related
complications
• If EPI lead necessary, steroid-eluting
leads recommended
J Thorac Cardiovasc Surg 1999;117:523-528
• Lead failure: 4 (epi) vs 4 (endo)
• Lead survival at 2 year: 91% (epi) vs 87% (endo)
• Steroid-eluting epi leads have the same
longevity as the conventional endo lead
• Pacing and sensing are similar
• Steroid-eluting epi leads are good alternatives
for endo leads for small children
PACE 2009:32:779-785
Compared to epi lead, transvenous atrial
pacing lead may be placed in Fontan patients
with lower procedure morbidity and
expectation of lead performance and
longevity.
• 3 DDD cases after surgery
• atrial lead characteristics: sensing threshold impedance lead
pt.1 at impant(17y) 4.5mv 0.6V/0.4ms 650 passive
follow-up(4y) 2.5mv no capture 680
pt.2 at impant(34y) 2.2mv 0.5V/0.4ms 720 active
follow-up(41y) 2.0mv 0.5V/0.4ms 700
pt.3 at impant(14y) 3.0mv 1.0V/0.4ms 690 active
follow-up(3y) 2.5mv 1.2V/0.4ms 720
conclusions
• The placement of atrial lead: endocardial and epicardial• Endocardial: screw-in, older children• Epicardial: steroid-eluting lead recommended small body size Fontan-type procedures tricuspid valve replacement• Follow-up
Thanks for your attention!